SCHEMBL26260024

SCHEMBL26260024

COc1ccc2c(-c3ncco3)c(OC)cc(-c3ncco3)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.39
▸ HCRTR2 O43614 1/20 0.39
▸ LMNA P02545 1/20 0.37
▸ DYRK1A Q13627 3/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ DYRK3 O43781 1/20 0.36
▸ CCNT1 O60563 1/20 0.36
▸ CCNB2 O95067 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CCNB1 P14635 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26260076 0.80 HIF1A (0.41) LMNAKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL27895648 0.79 ALDH1A1 (0.51) HCRTR1HCRTR2LMNAKDM4EALDH1A1
SCHEMBL27895619 0.79 ALDH1A1 (0.52) HCRTR1HCRTR2KDM4EALDH1A1HPGD
SCHEMBL14108017 0.76 HCRTR1 (0.46) HCRTR1HCRTR2LMNADYRK1AKDM4E
SCHEMBL26260063 0.72 CLK4 (0.44) DYRK1AKDM4EDYRK3CCNT1CCNB2
SCHEMBL17392495 0.72 HSP90AA1 (0.44) HCRTR1HCRTR2LMNADYRK1AKDM4E
SCHEMBL4899751 0.72 NOS3 (0.46) HCRTR1HCRTR2LMNADYRK1AKDM4E
SCHEMBL26259490 0.70 RAB9A (0.47) DYRK1AKDM4EALDH1A1HPGDCCNA2
SCHEMBL26260030 0.70 RAB9A (0.44) LMNAKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL14084344 0.70 HCRTR1 (0.41) HCRTR1HCRTR2LMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 HCRTR1 4208/4885HCRTR2 3899/4885LMNA 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback